Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tingley

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 5, 2009
The discovery of a structurally novel class of inhibitors of the type 1 glycine transporterJohn A Lowe, Xinjun Hou, Christopher Schmidt, et al.
Journal of Medicinal Chemistry|February 22, 2008
2-aryloxy-4-alkylaminopyridines: discovery of novel corticotropin-releasing factor 1 antagonistsYuhpyng L Chen, R Scott Obach, John Braselton, et al.
Diabetes|June 22, 2023
Identification of Hypothalamic Glucoregulatory Neurons That Sense and Respond to Changes in GlycemiaJennifer D Deem, David Tingley, Anne-Mette Bjerregaard, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2005
In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisineJotham W Coe, Michael G Vetelino, Crystal G Bashore, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2005
3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessationJotham W Coe, Paige R Brooks, Michael C Wirtz, et al.
Journal of Medicinal Chemistry|March 4, 2011
1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 positive allosteric modulators for the treatment of psychosisLei Zhang, Michael A Brodney, John Candler, et al.
Neuropharmacology|July 19, 2011
Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brainChristine A Strick, Cheryl Li, Liam Scott, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2010
A novel series of [3.2.1] azabicyclic biaryl ethers as alpha3beta4 and alpha6/4beta4 nicotinic receptor agonistsJohn A Lowe, Shari L DeNinno, Jotham W Coe, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Simultaneous, real-time tracking of many neuromodulatory signals with Multiplexed Optical Recording of Sensors on a micro-EndoscopePeter N Kalugin, Paul A Soden, Crystian I Massengill, et al.
Journal of Medicinal Chemistry|May 13, 2005
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessationJotham W Coe, Paige R Brooks, Michael G Vetelino, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|May 5, 2009
The discovery of a structurally novel class of inhibitors of the type 1 glycine transporterJohn A Lowe, Xinjun Hou, Christopher Schmidt, et al.
Journal of Medicinal Chemistry|February 22, 2008
2-aryloxy-4-alkylaminopyridines: discovery of novel corticotropin-releasing factor 1 antagonistsYuhpyng L Chen, R Scott Obach, John Braselton, et al.
Diabetes|June 22, 2023
Identification of Hypothalamic Glucoregulatory Neurons That Sense and Respond to Changes in GlycemiaJennifer D Deem, David Tingley, Anne-Mette Bjerregaard, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2005
In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisineJotham W Coe, Michael G Vetelino, Crystal G Bashore, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2005
3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessationJotham W Coe, Paige R Brooks, Michael C Wirtz, et al.
Journal of Medicinal Chemistry|March 4, 2011
1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 positive allosteric modulators for the treatment of psychosisLei Zhang, Michael A Brodney, John Candler, et al.
Neuropharmacology|July 19, 2011
Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brainChristine A Strick, Cheryl Li, Liam Scott, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2010
A novel series of [3.2.1] azabicyclic biaryl ethers as alpha3beta4 and alpha6/4beta4 nicotinic receptor agonistsJohn A Lowe, Shari L DeNinno, Jotham W Coe, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Simultaneous, real-time tracking of many neuromodulatory signals with Multiplexed Optical Recording of Sensors on a micro-EndoscopePeter N Kalugin, Paul A Soden, Crystian I Massengill, et al.
Journal of Medicinal Chemistry|May 13, 2005
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessationJotham W Coe, Paige R Brooks, Michael G Vetelino, et al.
Pageof 4